BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 33652579)

  • 41. A systematic overview of chemotherapy effects in colorectal cancer.
    Ragnhammar P; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Palliative Vitamin C Application in Patients with Radiotherapy-Resistant Bone Metastases: A Retrospective Study.
    Günes-Bayir A; Kiziltan HS
    Nutr Cancer; 2015; 67(6):921-5. PubMed ID: 26168394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Comparative study of different chemotherapy approaches for advanced epithelial ovarian cancer].
    Chen YL; Liu YQ; Tang DH; Chu CN
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):110-4. PubMed ID: 18683749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review.
    Jacobs C; Hutton B; Ng T; Shorr R; Clemons M
    Oncologist; 2015 Feb; 20(2):210-23. PubMed ID: 25601965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of Cancer-Related Fatigue, Pain, and Quality of Life in Cancer Patients at Palliative Care Team Referral: A Multicenter Observational Study (JORTC PAL-09).
    Iwase S; Kawaguchi T; Tokoro A; Yamada K; Kanai Y; Matsuda Y; Kashiwaya Y; Okuma K; Inada S; Ariyoshi K; Miyaji T; Azuma K; Ishiki H; Unezaki S; Yamaguchi T
    PLoS One; 2015; 10(8):e0134022. PubMed ID: 26244975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review.
    Jong JM; Oprea-Lager DE; Hooft L; de Klerk JM; Bloemendal HJ; Verheul HM; Hoekstra OS; van den Eertwegh AJ
    Eur Urol; 2016 Sep; 70(3):416-26. PubMed ID: 26391636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Carotenoids in Palliative Care-Is There Any Benefit from
    Zasowska-Nowak A; Nowak PJ; Cialkowska-Rysz A
    Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956359
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Intravenous Vitamin C Administration in Reducing Severity of Symptoms in Breast Cancer Patients During Treatment.
    Mansoor F; Kumar S; Rai P; Anees F; Kaur N; Devi A; Kumar B; Memon MK; Khan S
    Cureus; 2021 May; 13(5):e14867. PubMed ID: 34113504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review.
    van Gorkom GNY; Lookermans EL; Van Elssen CHMJ; Bos GMJ
    Nutrients; 2019 Apr; 11(5):. PubMed ID: 31035414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue.
    Minton O; Richardson A; Sharpe M; Hotopf M; Stone P
    J Natl Cancer Inst; 2008 Aug; 100(16):1155-66. PubMed ID: 18695134
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of modafinil in the treatment of cancer-related fatigue.
    Cooper MR; Bird HM; Steinberg M
    Ann Pharmacother; 2009 Apr; 43(4):721-5. PubMed ID: 19318599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.
    Riordan HD; Riordan NH; Jackson JA; Casciari JJ; Hunninghake R; González MJ; Mora EM; Miranda-Massari JR; Rosario N; Rivera A
    P R Health Sci J; 2004 Jun; 23(2):115-8. PubMed ID: 15377059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous vitamin C administration improves quality of life in breast cancer patients during chemo-/radiotherapy and aftercare: results of a retrospective, multicentre, epidemiological cohort study in Germany.
    Vollbracht C; Schneider B; Leendert V; Weiss G; Auerbach L; Beuth J
    In Vivo; 2011; 25(6):983-90. PubMed ID: 22021693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vitamin C pharmacokinetics: implications for oral and intravenous use.
    Padayatty SJ; Sun H; Wang Y; Riordan HD; Hewitt SM; Katz A; Wesley RA; Levine M
    Ann Intern Med; 2004 Apr; 140(7):533-7. PubMed ID: 15068981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase I trial of bortezomib and concurrent external beam radiation in patients with advanced solid malignancies.
    Pugh TJ; Chen C; Rabinovitch R; Eckhardt SG; Rusthoven KE; Swing R; Raben D
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):521-6. PubMed ID: 20133082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Palliative care for patients with mesothelioma.
    Tinkler M; Royston R; Kendall C
    Br J Hosp Med (Lond); 2017 Apr; 78(4):219-225. PubMed ID: 28398901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer.
    Ohno S; Ohno Y; Suzuki N; Soma G; Inoue M
    Anticancer Res; 2009 Mar; 29(3):809-15. PubMed ID: 19414313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Palliative chemotherapy in cancer patients].
    Katayama H; Katsumata N
    Nihon Rinsho; 2007 Jan; 65(1):98-102. PubMed ID: 17233423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reevaluation of ascorbate in cancer treatment: emerging evidence, open minds and serendipity.
    Padayatty SJ; Levine M
    J Am Coll Nutr; 2000 Aug; 19(4):423-5. PubMed ID: 10963459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer.
    Auret KA; Schug SA; Bremner AP; Bulsara M
    J Pain Symptom Manage; 2009 Apr; 37(4):613-21. PubMed ID: 18790598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.